Informacje dodatkowe
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | Rare, but possible |
| Lab Test | Monitoring of liver enzymes and metabolic indicators may be required |
| Strength | 50 mg |
| Also known as | Olanzapine |
| Blood pressure | May cause orthostatic hypotension |
| Trade name | Zyprexa |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
| Formula | C17H20N4S |
| Substance class | Thienobenzodiazepine |
| Main action | Antipsychotic |
| Half-life | Approximately 30 hours |
| Dosage (medical) | Typically 5-20 mg/day, adjusted based on patient response and condition |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilizing, reduction in agitation and hallucinations |
| Side effects | Weight gain, sedation, dry mouth, restlessness, elevated blood glucose levels |
| Use in sports | None |
| Manufacturer | Pharmaceutical |
Opinie
Na razie nie ma opinii o produkcie.